<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04789694</url>
  </required_header>
  <id_info>
    <org_study_id>PHOCUS_38/20</org_study_id>
    <nct_id>NCT04789694</nct_id>
  </id_info>
  <brief_title>Prehabilitation in Patients With Advanced Stage Ovarian Cancer Planned for Interval Debulking Surgery</brief_title>
  <acronym>PHOCUS</acronym>
  <official_title>Prehabilitation in Patients With Advanced Stage Ovarian Cancer Planned for Interval Debulking Surgery: a Single-blinded (Patient) Prospective Randomised Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charles University, Czech Republic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a strong evidence of positive effect of multimodal prehabilitation from prospective&#xD;
      controlled trials among patients treated surgically for non-gynaecological cancer. However,&#xD;
      the number of studies published on prehabilitation programs in gynaecologic surgery are&#xD;
      limited, especially in gynaecologic cancer patients. No study or trial comprehensively&#xD;
      evaluating a prehabilitation pathway for patients with extensive ovarian cancer has been&#xD;
      published so far.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The protocol summary and informed consent form will be made available on clinicaltrials.gov&#xD;
      when required.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional capacity changes</measure>
    <time_frame>9-12weeks</time_frame>
    <description>Six-minute walking test (6MWT)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Ovarian Cancer</condition>
  <condition>Ovarian Cancer Stage III</condition>
  <condition>Ovarian Cancer Stage IV</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low intensity support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High intensity support</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physiological intervention</intervention_name>
    <description>Rehabilitation specialist consultation&#xD;
Functional capacity measuring</description>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychological intervention</intervention_name>
    <description>Clinical psychologist consultation&#xD;
Anxiety and depression scoring&#xD;
Psychological support</description>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutritional intervention</intervention_name>
    <description>Nutritional specialist consultation&#xD;
Malnutrition scoring&#xD;
Dietary supplementation</description>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Epithelial ovarian cancer&#xD;
&#xD;
          -  FIGO stage III or IV disease&#xD;
&#xD;
          -  Patient is not a candidate for primary debulking surgery&#xD;
&#xD;
          -  Patient is a suitable candidate for standard of care combined chemotherapy&#xD;
&#xD;
          -  Patient is a candidate for interval debulking surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-epithelial ovarian cancer&#xD;
&#xD;
          -  Extraovarian tumor&#xD;
&#xD;
          -  Second malignant tumour (under the treatment)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Cibula, prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charles University, Czech Republic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jana Stribrna</last_name>
    <phone>+420 224 967 432</phone>
    <email>jana.stribrna@vfn.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefan Lednicky, MD.</last_name>
    <email>stefan.lednicky@vfn.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gynecologic Oncology Center in Prague</name>
      <address>
        <city>Prague</city>
        <zip>12000</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Cibula, M.D.</last_name>
      <phone>+420603547055</phone>
      <email>dc@davidcibula.cz</email>
    </contact>
    <contact_backup>
      <last_name>Jana Stribrna</last_name>
      <phone>+420224967432</phone>
      <email>jana.stribrna@vfn.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 1, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charles University, Czech Republic</investigator_affiliation>
    <investigator_full_name>David Cibula</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Prehabilitation</keyword>
  <keyword>Epitelial ovarian cancer</keyword>
  <keyword>Functional capacity</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Multimodal prehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ovarian Epithelial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

